Enhanced outcomes for coronary artery disease obtained by a multidisciplinary heart team approach

Yamasaki, Manabu; Abe, Kohei; Horikoshi, Rihito; Hoshino, Eri; Yanagisawa, Hiromi; Yoshino, Kunihiko; Misumi, Hiroyasu; Mizuno, Atsushi; Komiyama, Nobuyuki

doi:10.1007/s11748-019-01108-4

Cited by 27 publications

(27 citation statements)

References 25 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…Models include daily to weekly scheduled meetings and ad hoc activation. 1,2,4,6,9 Remote conferences have also been advocated. 9 Additionally, there should be a process for rapid activation of the Heart Team for urgent or emergency clinical situations.…”

Section: Preprocedural Assessment and The Heart Teammentioning

confidence: 99%

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

et al. 2022

View full text Add to dashboard Cite

Aim: The guideline for coronary artery revascularization replaces the 2011 coronary artery bypass graft surgery and the 2011 and 2015 percutaneous coronary intervention guidelines, providing a patient-centric approach to guide clinicians in the treatment of patients with significant coronary artery disease undergoing coronary revascularization as well as the supporting documentation to encourage their use. Methods: A comprehensive literature search was conducted from May 2019 to September 2019, encompassing studies, reviews, and other evidence conducted on human subjects that were published in English from PubMed, EMBASE, the Cochrane Collaboration, CINHL Complete, and other relevant databases. Additional relevant studies, published through May 2021, were also considered. Structure: Coronary artery disease remains a leading cause of morbidity and mortality globally. Coronary revascularization is an important therapeutic option when managing patients with coronary artery disease. The 2021 coronary artery revascularization guideline provides recommendations based on contemporary evidence for the treatment of these patients. The recommendations present an evidence-based approach to managing patients with coronary artery disease who are being considered for coronary revascularization, with the intent to improve quality of care and align with patients’ interests.

show abstract

Section: Preprocedural Assessment and The Heart Teammentioning

confidence: 99%

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

et al. 2022

View full text Add to dashboard Cite

show abstract

“…Moreover, a heart team approach may provide better outcomes, as suggested by favorable outcomes in the registry arms of randomized controlled trials and routine clinical practice. [15][16][17] Recent evidence further shows that utilizing a structured heart team form and a formal interventional cardiology consultative service can improve the operation of a CAD heart team. 18 Therefore, the use of the CAD heart team is encouraged for guiding revascularization decision-making for patients with complex CAD.…”

Section: Utilization Of the Cad Heart Teammentioning

confidence: 99%

“…Group discussions can center around patient‐specific presentation and comorbidities, calculation of various risk scores, and implementation of society guideline recommendations to facilitate decision‐making. Moreover, a heart team approach may provide better outcomes, as suggested by favorable outcomes in the registry arms of randomized controlled trials and routine clinical practice 15‐17 . Recent evidence further shows that utilizing a structured heart team form and a formal interventional cardiology consultative service can improve the operation of a CAD heart team 18 .…”

Section: Preprocedural Assessment Of Coronary Anatomical Complexity Amentioning

confidence: 99%

SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease

Riley

Henry

Mahmud

et al. 2020

Cathet Cardio Intervent

View full text Add to dashboard Cite

“…A “Heart Team” comprising primarily of cardiologists and cardiothoracic surgeons, helps achieve a multi-disciplinary consensus and is seen to improve outcomes. 64 Scoring systems such as EUROscore and SYNTAX also guide decision making. EuroSCORE I & II predict mortality post-cardiac surgery.…”

Section: Section III Cabg Now and Pci For The Future?mentioning

confidence: 99%

Coronary revascularization in patients with stable coronary disease and diabetes mellitus

Bhat

Yatsynovich

Sharma

2021

Diabetes and Vascular Disease Research

View full text Add to dashboard Cite

Purpose of Study: Diabetes mellitus accelerates the development of atherosclerosis. Patients with diabetes mellitus have higher incidence and mortality rates from cardiovascular disease and undergo a disproportionately higher number of coronary interventions compared to the general population. Proper selection of treatment modalities is thus paramount. Treatment strategies include medical management and interventional approaches including coronary artery bypass graft (CABG) surgery and percutaneous coronary interventions (PCI). The purpose of this review is to assimilate emerging evidence comparing CABG to PCI in patients with diabetes and present an outlook on the latest advances in percutaneous interventions, in addition to the optimal medical therapies in patients with diabetes. Key Methods: A systematic search of PubMed, Web of Science and EMBASE was performed to identify prospective, randomized trials comparing outcomes of CABG and PCI, and also PCI with different generations of stents used in patients with diabetes. Additional review of bibliography of selected studies was also performed. Main Conclusions: Most of the trials discussed above demonstrate a survival advantage of CABG over PCI in patients with diabetes. However, recent advances in PCI technology are starting to challenge this narrative. Superior stent designs, use of specific drug-eluting stents, image-guided stent deployment, and the use of contemporary antiplatelet and lipid-lowering therapies are continuing to improve the PCI outcomes. Prospective data for such emerging interventional technologies in diabetes is however lacking currently and is the need of the hour.

show abstract

Enhanced outcomes for coronary artery disease obtained by a multidisciplinary heart team approach

Cited by 27 publications

References 25 publications

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

SCAI position statement on optimal percutaneous coronary interventional therapy for complex coronary artery disease

Coronary revascularization in patients with stable coronary disease and diabetes mellitus

Contact Info

Product

Resources

About